These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20332450)

  • 1. Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells.
    Bachawal SV; Wali VB; Sylvester PW
    Anticancer Res; 2010 Feb; 30(2):429-37. PubMed ID: 20332450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
    Bachawal SV; Wali VB; Sylvester PW
    BMC Cancer; 2010 Mar; 10():84. PubMed ID: 20211018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
    Wali VB; Bachawal SV; Sylvester PW
    Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells.
    Samant GV; Sylvester PW
    Cell Prolif; 2006 Dec; 39(6):563-74. PubMed ID: 17109639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment.
    Akl MR; Ayoub NM; Sylvester PW
    Planta Med; 2012 Nov; 78(16):1731-9. PubMed ID: 22987298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity.
    Shah SJ; Sylvester PW
    Exp Biol Med (Maywood); 2005 Apr; 230(4):235-41. PubMed ID: 15792944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells.
    Wali VB; Sylvester PW
    Lipids; 2007 Dec; 42(12):1113-23. PubMed ID: 17701065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
    Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
    Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
    Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxazine derivatives of γ- and δ-tocotrienol display enhanced anticancer activity in vivo.
    Ananthula S; Parajuli P; Behery FA; Alayoubi AY; El Sayed KA; Nazzal S; Sylvester PW
    Anticancer Res; 2014 Jun; 34(6):2715-26. PubMed ID: 24922632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling.
    Shirode AB; Sylvester PW
    Biomed Pharmacother; 2010 May; 64(5):327-32. PubMed ID: 19954924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells.
    Parajuli P; Tiwari RV; Sylvester PW
    Cell Prolif; 2015 Aug; 48(4):421-35. PubMed ID: 26096843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
    Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
    Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of gefitinib and erlotinib on apoptosis and c-MYC expression in H23 lung cancer cells.
    Suenaga M; Yamamoto M; Tabata S; Itakura S; Miyata M; Hamasaki S; Furukawa T
    Anticancer Res; 2013 Apr; 33(4):1547-54. PubMed ID: 23564796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Rac1/WAVE2 Signaling in Mediating the Inhibitory Effects of γ-Tocotrienol on Mammary Cancer Cell Migration and Invasion.
    Algayadh IG; Dronamraju V; Sylvester PW
    Biol Pharm Bull; 2016; 39(12):1974-1982. PubMed ID: 27904039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of gamma-tocotrienol in neoplastic mammary epithelial cells.
    Sylvester PW; Shah SJ; Samant GV
    J Plant Physiol; 2005 Jul; 162(7):803-10. PubMed ID: 16008108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells.
    Wali VB; Bachawal SV; Sylvester PW
    Apoptosis; 2009 Nov; 14(11):1366-77. PubMed ID: 19771520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors.
    Choi YJ; Rho JK; Jeon BS; Choi SJ; Park SC; Lee SS; Kim HR; Kim CH; Lee JC
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):381-8. PubMed ID: 19921194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
    Hsieh TC; Wu JM
    Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.